Allen Institute for Artificial Intelligence
supp.ai logo
supp.ai

Discover Supplement-Drug Interactions

Disclaimer: The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The tool is not a substitute for the care provided… (more)
Last Updated: 5 years ago

Possible Interaction: Quinacrine and Masoprocol

supplement:

Masoprocol

Research Papers that Mention the Interaction

“Preincubation of cells with quinacrine , an inhibitor of phospholipase A2, or with the lipoxygenase inhibitors 5,8,11,14-eicosatetraynoic acid or nordihydroguaiaretic acid prior to thrombin challenge resulted in a concentration-dependent attenuation of the response.”
The Journal of biological chemistry  •  1984  |  View Paper
“ Nordihydroguaiaretic acid (a lipoxygenase inhibitor) significantly potentiated the suppressive activity whereas quinacrine (a phospholipase A2 inhibitor) and indomethacin (a cyclooxygenase inhibitor) did not significantly affect it.”
European journal of pharmacology  •  1992  |  View Paper
“Combined pretreatment with quinacrine dihydrochloride and nordihydroguaiaretic acid almost completely abolished the S-ropivacaine-induced contraction.”
Canadian journal of anaesthesia = Journal canadien d'anesthesie  •  2009  |  View Paper
“Similarly, the phospholipase A2 inhibitor quinacrine (50 microM) and an inhibitor of AA metabolism, nordihydroguaiaretic acid ( NDGA ; 50 microM), reduced the GH responses to SKF38393, forskolin, and 8Br-cAMP.”
General and comparative endocrinology  •  1996  |  View Paper
“2 Nordihydroguäiaretic acid (NDGA; 5 × 10−6 m), an inhibitor of lipoxygenase and quinacrine (10−5 m), which blocks the release of arachidonic acid from phospholipids by inhibiting the enzyme phospholipase A2, blocked hypoxia‐induced contractions.”
British journal of pharmacology  •  1991  |  View Paper
“The relaxation produced by the inhibitory factor was unaffected by quinacrine and flurbiprofen while nordihydroguaiaretic acid potentiated the response.”
British journal of pharmacology  •  1986  |  View Paper
“ Mepacrine , a phospholipase A2 inhibitor (3 X 10(-5) M) and the lipoxygenase inhibitor nordihydroguaiaretic acid (10(-5) M) inhibited this response whereas the cyclooxygenase inhibitor, diclofenac sodium (10(-5) M), and the thromboxane synthetase inhibitor imidazole (10(-5) M) did not.”
European journal of pharmacology  •  1986  |  View Paper